Skip Navigation

Details for High Impact Journal

Superfund Research Program

Blood (impact factor: 22.113)

2021

  • Yu X, Li W, Deng Q, Liu H, Wang X, Hu H, Cao Y, Xu-Monette ZY, Li L, Zhang M, Lu Z, Young KH, Li Y. 2021. MYD88 L265P elicits mutation-specific ubiquitination to drive NF-(kappa)B activation and lymphomagenesis. Blood 137(12):1615-1627. doi:10.1182/blood.2020004918 PMID:33025009 PMCID:PMC7995293

2019

  • Brown AL, de Smith AJ, Gant VU, Yang W, Scheurer ME, Walsh KM, Chernus JM, Kallsen NA, Peyton SA, Davies GE, Ehli EA, Winick N, Heerema NA, Carroll AJ, Borowitz MJ, Wood BL, Carroll WL, Raetz EA, Feingold E, Devidas M, Barcellos L, Hansen HM, Morimoto L, Kang AY, Smirnov I, Healy J, Laverdiere C, Sinnett D, Taub JW, Birch JM, Thompson P, Spector LG, Pombo-de-Oliveira MS, DeWan AT, Mullighan CG, Hunger SP, Pui C, Loh ML, Zwick ME, Metayer C, Ma X, Mueller BA, Sherman SL, Wiemels JL, Relling MV, Yang J, Lupo PJ, Rabin KR. 2019. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome. Blood 134:1227-1237. PMID:31350265

2016

  • Chapuy B, Cheng H, Watahiki A, Ducar M, Tan Y, Chen L, Roemer M, Ouyang J, Christie A, Zhang L, Gusenleitner D, Abo R, Farinha P, von Bonin F, Thorner A, Sun H, Gascoyne R, Pinkus G, van Hummelen P, Wulf G, Aster J, Weinstock D, Monti S, Rodig S, Wang Y, Shipp M. 2016. Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease. Blood 127(18):2203-2213. doi:10.1182/blood-2015-09-672352 PMID:26773040 PMCID:PMC4859195

2014

  • de Smith AJ, Walsh KM, Ladner MB, Zhang S, Xiao C, Cohen F, Moore TB, Chokkalingam AP, Metayer C, Buffler PA, Trachtenberg EA, Wiemels JL. 2014. The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia. Blood 123:2497-2503. doi:10.1182/blood-2013-11-540625 PMID:24518758 PMCID:PMC3990912

2013

  • Hira A, Yabe H, Yoshida K, Okuno Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Nakamura J, Kojima S, Ogawa S, Matsuo K, Takata M, Yabe M. 2013. Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. Blood 122(18):3206-3209. doi:10.1182/blood-2013-06-507962 PMID:24037726 PMCID:PMC3953058
  • Smith BW, Rozelle SS, Leung A, Ubellacker J, Parks A, Nah SK, French D, Gadue P, Monti S, Chui DK, Steinberg MH, Frelinger AL, Michelson AD, Theberge R, McComb ME, Costello CE, Kotton DN, Mostoslavsky G, Sherr DH, Murphy GJ. 2013. The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation. Blood 122:376-385. doi:10.1182/blood-2012-11-466722 PMID:23723449 PMCID:PMC3716202

2010

2008

2003

  • McHale CM, Wiemels JL, Zhang L, Ma X, Buffler PA, Feusner J, Matthay KK, Dahl GV, Smith MT. 2003. Prenatal origin of childhood acute myeloid leukemias harboring chromosomal rearrangements t(15;17) and inv(16). Blood 101(11):4640-4641. PMID:12756163

2002

  • Skibola CF, Smith MT, Hubbard AE, Shane B, Roberts AC, Law GR, Rollinson S, Roman E, Cartwright RA, Morgan GJ. 2002. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 99(10):3786-3791. PMID:11986237
  • Wiemels JL, Xiao Z, Buffler PA, Maia AT, Ma X, Dicks BM, Smith MT, Zhang L, Feusner J, Wiencke JK, Pritchard-Jones K, Kempski H, Greaves MF. 2002. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood 99(10):3801-3805. PMID:11986239

2001

  • Ulrich CM, Yasui Y, Storb RF, Schubert MM, Wagner JL, Bigler J, Ariail KS, Keener CL, Li S, Liu H, Farin FM, Potter JD. 2001. Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood 98(1):231-234. PMID:11418485

1998

  • Broudy VC, Lin NL, Buhring H, Komatsu N, Kavanagh TJ. 1998. Analysis of c-Kit receptor dimerization by fluorescence resonance energy transfer. Blood 91:898-906. PMID:9446650
  • Calverley DC, Kavanagh TJ, Roth GJ. 1998. Human signaling protein 14-3-3 zeta interacts with platelet glycoprotein Ib subunits Ib alpha and Ib beta. Blood 91(4):1295-1303. PMID:9454760
  • Jeng M, Holland NT, Smith MT. 1998. A comparison of cytogenetic damage in human hematopoietic CD34+ progenitor cells and peripheral blood lymphocytes. Blood 92(10,supp.1):
Back
to Top